Evidence
Case Rep Psychiatry. 2024 Feb 20;2024:9147674. doi: 10.1155/2024/9147674. eCollection 2024.
ABSTRACT
Clozapine is an antipsychotic medicine used to treat mental illnesses that is resistant to therapy. It can induce dose-dependent adverse effects such as increased susceptibility to infections and hematological irregularities. In this case report, we present a 37-year-old woman with schizoaffective disorder who experienced clozapine side effects following a moderate urinary tract infection (UTI). Her serum clozapine levels and side effects were increased throughout her UTI but resolved once the UTI was managed conservatively. We reviewed clozapine’s pharmacokinetic properties to understand why serum levels rose during infection. While we could not definitely explain the mechanism of elevation, we emphasize the importance of monitoring serum clozapine levels and keeping watchful for adverse effects, as well as heightened scrutiny, evaluation for recent infections, and regular monitoring of patients.
PMID:38414905 | PMC:PMC10898943 | DOI:10.1155/2024/9147674
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
A Case Report of a Patient with Soaring Clozapine Levels after Developing a Urinary Tract Infection
🌐 90 Days
VR Related Evidence Matrix
- Successful Clozapine Rechallenge After Clozapine-Induced Severe Anemia: A Case Report
- Change in absolute neutrophil count after COVID-19 infection in patients using clozapine versus other antipsychotics
- A systematic review of clozapine for aggression and violence in patients with schizophrenia or schizoaffective disorder
- Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug
- Knee Buckling as an Atypical Adverse Effect of Clozapine: A Case Report
- Patient safety: adverse effects of Clozapine and their management at the Psychiatric Hospital Ghrasia in Yogyakarta, Indonesia
- Clozapine Withdrawal Catatonia: A Case Report
- Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature
- Prediction of Postoperative Urinary Tract Infection Following Benign Gynecologic Surgery
- Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature
- Potential impact on mental health in patients with treatment-resistant schizophrenia - clozapine augmentation with long-acting parenteral antipsychotics: a case series
- Potential impact on mental health in patients with treatment-resistant schizophrenia - clozapine augmentation with long-acting parenteral antipsychotics: a case series
- Optimizing co-prescription of clozapine and antiseizure medications: a systematic review and expert recommendations for clinical practice
- Safety of BEN guidelines in clozapine treatment: A Canadian perspective
- Higher orexin-A levels are associated with treatment response to clozapine in patients with schizophrenia: A cross-sectional study
- Polymorphisms in ERBB4 and TACR1 associated with dry mouth in clozapine-treated patients
- Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data
- Overcoming Obstacles to Clozapine Treatment: A Case of Clozapine Rechallenge in ECT-Resistant Schizophrenia With Catatonic Features
- Comparative Study of the Efficacy and Side Effects of Brand-Name and Generic Clozapine for Long-Term Maintenance Treatment Among Korean Patients With Schizophrenia: A Retrospective Naturalistic Mirror-Image Study
- Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review
- Real-World Effectiveness of High-Dose Olanzapine and Clozapine for Treatment-Resistant Schizophrenia in Japan: A Retrospective Bidirectional Mirror-Image Study
- Clinical and pharmacological factors influencing serum clozapine and norclozapine levels
- Sean Crawford: Prevention of future deaths report
- Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis
- Spinal Deformity Manifested by Urinary Tract Infection: A Case of Acute-on-Chronic Mobility Dysfunction
- Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication
- Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder
- Cystocerebral Syndrome in a Patient with Altered Mental Status
- Clozapine-laden carbon dots delivered to the brain via an intranasal pathway: Synthesis, characterization, ex vivo, and in vivo studies
- Second-generation antipsychotics for Parkinson's disease psychosis: A systematic review and network meta-analysis
- Clozapine Treatment for Aggressive Behaviors in Youths with Neurodevelopmental Disorders
- Tau and delirium superimposed on dementia: A case report
- Relationship Between Clozapine and Non-Hematological Malignant Tumors: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System Database
- Review of Risk Factors, Pathophysiology, Management Principles, and Role of Medications
- Chromatographic Methods for the Analysis of the Antipsychotic Drug Clozapine and Its Major Metabolites: A Review
- The magnitude of the plasma hepcidin response to oral iron supplements depends on the iron dosage
- Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder
- Clozapine-Associated Myocarditis in a Patient With Schizophrenia Taking Lemborexant: A Case Report
- Comparison of outcomes in patients with and without neurologic diseases undergoing holmium laser enucleation of the prostate
- Sinus Node Dysfunction and Pulmonary Hypertension-"Double Trouble" with Lithium Therapy
- Transient Fever Response After ECT in a Patient with Catatonic Schizophrenia: A Case Report
- Fluoroquinolones: Neurological Complications and Side Effects in Clinical Practice
- Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics
- Response rates to sequential trials of antipsychotic medications according to algorithms or treatment guidelines in psychotic disorders. A systematic review and meta-analysis
- Response rates to sequential trials of antipsychotic medications according to algorithms or treatment guidelines in psychotic disorders. A systematic review and meta-analysis
- Acute psychosis in a 35-year-old woman. Could it be related to a previous COVID-19 infection? A case report
- Neurophysiological treatment effects of mesdopetam, pimavanserin and clozapine in a rodent model of Parkinson's disease psychosis
- Associations of the Gut Microbiome With Treatment Resistance in Schizophrenia
- A Rare Case of an Eosinophilic Pleural Effusion and Loculated Ascites Associated with Strongyloides stercoralis Hyperinfection Syndrome in California
- When Imagination Feels Like Reality: A Case Study of False Memories and Maladaptive Daydreaming in Visual Impairment
- Glutamate and GABA levels in the anterior cingulate cortex in treatment resistant first episode psychosis patients
- Psychotropic Management in Cotard Syndrome: Case Reports Supporting Dual Medication Management
- Clozapine Prescripers-Dogmatic or Pragmatic?
- A Rare Cause of Empyema and Bacteremia Due to Shewanella Species in Alcoholic Cirrhosis Patients: A Case Report and Comprehensive Review of Literature
- A Clinical Suspicion of Quetiapine-Induced Psychosis: A Case Report and Literature Review
- Seizures, Psychosis, and Cerebral Vascular Malformation: A Rare Chain of Events
- Organic dyspepsia until proven otherwise
- Kratom-Induced Psychiatric Decompensation and Paranoid Delusions
- COVID-19-induced acute loss of consciousness in Marchiafava-Bignami disease: a case report
- Corticobasal degeneration with visual hallucination as an initial symptom: A case report
- Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia- a case series
- New Antibiotics for the Treatment of Nosocomial Central Nervous System Infections
- History Is the Key to Diagnosis: A Case of Nitrofurantoin-Induced Interstitial Lung Disease
- Higher T central and lower effector memory cells in bipolar disorder: A differentiation abnormality?
Evidence Blueprint
A Case Report of a Patient with Soaring Clozapine Levels after Developing a Urinary Tract Infection
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
A Case Report of a Patient with Soaring Clozapine Levels after Developing a Urinary Tract Infection
🌐 365 Days
VR Related Evidence Matrix
- Successful Clozapine Rechallenge After Clozapine-Induced Severe Anemia: A Case Report
- Change in absolute neutrophil count after COVID-19 infection in patients using clozapine versus other antipsychotics
- Clozapine-induced eosinophilia: A case report
- A systematic review of clozapine for aggression and violence in patients with schizophrenia or schizoaffective disorder
- Clozapine Serum Concentrations Are Disrupted by SARS-CoV-2 Vaccinations
- Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug
- Utilizing plasma drug levels and genetic testing to achieve optimal treatment response in a patient with treatment-resistant schizoaffective disorder
- Knee Buckling as an Atypical Adverse Effect of Clozapine: A Case Report
- Relationship between C-reactive protein and antipsychotics levels in schizophrenic patients infected with COVID-19
- Vaccination and clozapine use: a systematic review and an analysis of the VAERS database
- Patient safety: adverse effects of Clozapine and their management at the Psychiatric Hospital Ghrasia in Yogyakarta, Indonesia
- Clozapine Withdrawal Catatonia: A Case Report
- Clozapine-induced myocarditis and subsequent rechallenge: a narrative literature review and case report
- Rhabdomyolysis during adjunctive treatment with cariprazine in a clozapine-resistant schizophrenia patient
- Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature
- Prediction of Postoperative Urinary Tract Infection Following Benign Gynecologic Surgery
- Significant improvement of psychotic symptoms in treatment-resistant schizophrenia with clozapine in an adolescent with SHINE syndrome: a case report
- The ever-growing case for clozapine in the treatment of schizophrenia: an obligation for psychiatrists and psychiatry
- Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature
- Risk factors for lower respiratory tract infections in a psychiatric hospital: a retrospective study
- Digital remote monitoring for screening and early detection of urinary tract infections
- The Tarnished Legacy of a Wonder Drug: Revisiting the Complicated History of Clozapine
- Potential impact on mental health in patients with treatment-resistant schizophrenia - clozapine augmentation with long-acting parenteral antipsychotics: a case series
- Potential impact on mental health in patients with treatment-resistant schizophrenia - clozapine augmentation with long-acting parenteral antipsychotics: a case series
- A brief history of clozapine use in Taiwan
- Optimizing co-prescription of clozapine and antiseizure medications: a systematic review and expert recommendations for clinical practice
- Safety of BEN guidelines in clozapine treatment: A Canadian perspective
- Clozapine for the treatment of aggressiveness and agitation in advanced dementia
- The Challenge of Managing Refractory Psychosis Amid Multiple Medication Side Effects: A Case Report and Review of the Literature
- Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review
- Higher orexin-A levels are associated with treatment response to clozapine in patients with schizophrenia: A cross-sectional study
- Once-daily versus divided dosing regimens of clozapine: A cross-sectional study in Singapore
- Polymorphisms in ERBB4 and TACR1 associated with dry mouth in clozapine-treated patients
- Side effects of clozapine in older adults with treatment-resistant schizophrenia compared to younger adults
- Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data
- Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study
- Safety aspects during treatment with clozapine. : Monitoring and rechallenge - a narrative review
- Overcoming Obstacles to Clozapine Treatment: A Case of Clozapine Rechallenge in ECT-Resistant Schizophrenia With Catatonic Features
- Clozapine and its protective effect on all-cause, natural, and suicide mortality in patients with schizophrenia: A nationwide cohort study in Taiwan
- Comparative Study of the Efficacy and Side Effects of Brand-Name and Generic Clozapine for Long-Term Maintenance Treatment Among Korean Patients With Schizophrenia: A Retrospective Naturalistic Mirror-Image Study
- Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review
- Real-World Effectiveness of High-Dose Olanzapine and Clozapine for Treatment-Resistant Schizophrenia in Japan: A Retrospective Bidirectional Mirror-Image Study
- Cariprazine in an Adolescent with Tourette Syndrome with Comorbid Attention Deficit Hyperactive Disorder and Depression: A Case Report
- Clinical and pharmacological factors influencing serum clozapine and norclozapine levels
- Sean Crawford: Prevention of future deaths report
- Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis
- Spinal Deformity Manifested by Urinary Tract Infection: A Case of Acute-on-Chronic Mobility Dysfunction
- Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact
- Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review
- Clozapine-Associated Agranulocytosis: A Systematic Review. Is It Really So Frighteningly Common?
- Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions
- Current practice for clozapine-induced leukopenia in Japanese psychiatric hospitals: A nationwide survey
- Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication
- Therapeutic Drug Level Monitoring of Antipsychotics at an Inpatient Psychiatric Hospital
- Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder
- Cystocerebral Syndrome in a Patient with Altered Mental Status
- Schizophrenia patients discharged on clozapine plus long-acting injectable antipsychotics from a public psychiatric hospital in Taiwan, 2006-2021
- Clozapine-laden carbon dots delivered to the brain via an intranasal pathway: Synthesis, characterization, ex vivo, and in vivo studies
- An international research agenda for clozapine-resistant schizophrenia
- What are patients' experiences of discontinuing clozapine and how does this impact their views on subsequent treatment?
- Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia
- Cariprazine augmentation of clozapine in schizophrenia-a retrospective chart review
- Obsessive-Compulsive Symptoms and Disorder in Clozapine-treated Schizophrenia
- The Impact of Clozapine Delay on Clinical Outcomes in Schizophrenia